![IconJournalPUCSA [ENG] by Edgar Julian-Laime®](https://revistas.uncp.edu.pe/public/journals/29/pageHeaderLogoImage_en.png)
Risk factors associated with cervical cáncer in patients cared for at the Ramiro Priale National hospital 2019-2023
DOI:
https://doi.org/10.26490/pucsa.2276Keywords:
cervical cancer, older age, risk factors, Huancayo, sexual partnersAbstract
Cervical Cancer (CACU) is one of the leading causes of mortality in women in different developing countries, including Peru. It is a sexually transmitted disease caused by the Human Papillomavirus. Given that there is sociocultural diversity in the country and therefore, risk factors must vary by region, this work was carried out, with the objective of determining whether the age of first sexual intercourse, the use of oral contraceptives, the age of majority 40 years, origin from the jungle and number of sexual partners were a risk factor. A retrospective type of work was carried out on cases (patients with CACU) and controls (Patients without CACU). The sample studied was 75 cases and 150 controls (randomly chosen). The information obtained was from the Pap smear requests that all patients responded to at the initial visits. It was found that the following are considered risk factors: having had more than 3 sexual partners (OR=1.909)(p=0.023), being over 40 years old (OR=7.765)(p<0.001) and coming from the jungle. (OR=4.984)(p=0.02).It is concluded that only age is an important risk factor and that the others are of weak association. The first sexual relationship or the use of oral contraceptives is not a risk factor to consider.
Downloads
References
Pan American Health Organization. A cervical cancer-free future: first-ever global commitment to eliminate a cancer [Internet]. 2020. Disponible en: https://www.paho.org/en/news/17-11-2020-cervical-cancer-free-future-first-ever-global-commitment-eliminate-cancer
Collins JH, Bowie D, Shannon G. A descriptive analysis of health practices, barriers to healthcare, and the unmet need for cervical cancer screening in the lower napo river region of the peruvian amazon. Women’s Health. 2019;15:1745506519890969. doi:10.1177/1745506519890969
Buskwofie A, David-West G, Clare CA. A review of cervical cancer: incidence and disparities. J Natl Med Assoc. 2020;112(2):229–32. doi:10.1016/j.jnma.2020.03.002
Yousefi Z, Aria H, Ghaedrahmati F, Bakhtiari T, Azizi M, Bastan R, et al. An update on human papilloma virus vaccines: history, types, protection, and efficacy. Front Immunol. 2022;12:805695. doi:10.3389/fimmu.2021.805695
Kuroki-Yshii AM, Franco-Kuroki A, Alaba-Tucto K. Anticoncepción hormonal, aspectos sociodemográficos y de la conducta como factores de riesgo para cáncer de cuello uterino en un hospital en ica, perú. Rev Méd Panacea [Internet]. 2018;7(2). Disponible en: https://revistas.unica.edu.pe/index.php/panacea/article/view/19/255
Aranguren LV, Burbano JH, González JD, Mojica AM, Plazas DJ, Prieto BM. Barreras para la prevención y detección temprana de cáncer de cuello uterino. Investig Enferm: Imagen Desarro. 2017;19(2):129–43. doi:10.11144/Javeriana.ie19-2.bpdt
Gonzales GF, Villena A. Body mass index and age at menarche in peruvian children living at high altitude and at sea level. Hum Biol. 1996;68(2):265–75. PubMed PMID: 8838916.
Bhatla N, Aoki D, Sharma DN, Sankaranarayanan R. Cancer of the cervix uteri: 2021 update. Int J Gynaecol Obstet. 2021;155(S1):28–44. doi:10.1002/ijgo.13865
Li J, Liu G, Others. Cervical cancer prognosis and related risk factors for patients with cervical cancer: a long-term retrospective cohort study. Sci Rep. 2022;12:13994. doi:10.1038/s41598-022-17733-8
Johnson CA, James D, Marzan A, Armaos M. Cervical cancer: an overview of pathophysiology and management. Semin Oncol Nurs. 2019;35(2):166–74. doi:10.1016/j.soncn.2019.02.003
Zhang S, Xu H, Zhang L, Qiao Y. Cervical cancer: epidemiology, risk factors and screening. Chin J Cancer Res. 2020;32(6):720–8. doi:10.21147/j.issn.1000-9604.2020.06.05
Bovo AC, Pedrão PG, Guimarães YM, Godoy LR, Resende JCP, Longatto-Filho A. Combined oral contraceptive use and the risk of cervical cancer: literature review. Rev Bras Ginecol Obstet. 2023;45(12):e818–24. doi:10.1055/s-0043-1775183 PubMed PMID: 38141603.
Flores A. Conocimientos y riesgos sobre el VPH y su relación con el cáncer cervicouterino en mujeres entre 20 y 59 años de edad. RIDE Rev Iberoam Para Investig Desarro Educ. 2022;12(24). doi:10.23913/ride.v12i24.1186
Laberiano C. Estado del tamizaje del cáncer de cérvix en países de américa latina desde la perspectiva de los profesionales de salud. Rev Peru Ginecol Obstet. 2020;66(1):37–40. doi:10.31403/rpgo.v66i2231
Sánchez EA, Patiño N, Espinosa J, Quintero L, Bedoya A. Factores de riesgo para adquirir la infección por el virus del papiloma humano (VPH) y otras infecciones de transmisión sexual en mujeres estudiantes universitarias vacunadas y no vacunadas contra el VPH. Hechos Microbiol. 2016;7(1–2):12–20. doi:10.17533/udea.hm.335032
Sarmiento MI, Puerto M. Factores de riesgo para cáncer de cuello uterino y resultados de prueba de papanicolaou en adolescentes marginadas de bogotá, colombia. Rev Cienc Salud. 2020;18(1):37–51.
Córdova DJ, Holguín ML. Factores de riesgo predisponentes para el desarrollo de cáncer cervicouterino [Tesis de grado]. Universidad Estatal de Milagro; 2021.
Soria JR. Factores ginecológicos asociados a cáncer de cuello uterino en pacientes ambulatorios del hospital II essalud pucallpa en el periodo 2017 [Tesis de pregrado]. [Pucallpa]: Universidad Nacional de Ucayali; 2021.
Huamán MJ. Factores sociodemográficos relacionados al cáncer de cuello uterino en atenciones del hospital amazónico, periodo 2021 [Tesis de pregrado]. [Pucallpa]: Universidad Nacional de la Amazonía Peruana; 2023.
Williamson J, Ramirez R, Wingfield T. Health, healthcare access, and use of traditional versus modern medicine in remote peruvian amazon communities: a descriptive study of knowledge, attitudes, and practices. Am J Trop Med Hyg. 2015;92(4):857–64. doi:10.4269/ajtmh.14-0535
Brierley CK, Suarez N, Arora G, Graham D. Healthcare access and health beliefs of the indigenous peoples in remote amazonian peru. Am J Trop Med Hyg. 2014;90(2):180–3. doi:10.4269/ajtmh.13-0319
Bruni L, Albero G, Serrano B, Mena M, Gómez D, Muñoz J, et al. Human papillomavirus and related diseases: Peru [Internet]. 2019. Disponible en: https://hpvcentre.net/statistics/reports/PER.pdf
Ochoa FJ, Guarneros DB, Velasco MT. Infección por virus del papiloma humano en mujeres y su prevención. Gac Mex Oncol. 2015;14(3):157–63. doi:10.1016/j.gamo.2015.05.001
Peng Y, Wang X, Feng H, Yan G. Is oral contraceptive use associated with an increased risk of cervical cancer? An evidence-based meta-analysis. J Obstet Gynaecol Res. 2017;43(5):913–22. doi:10.1111/jog.13291
Waiswa A, Nsubuga R, Muwasi M, Kimera I, Ndikabona G, Tusingwire PD, et al. Knowledge and attitude towards cervical cancer screening among females attending outpatient department in health centre IIIs in oyam district. OPEN J Prev Med. 2017;7(5):55–62. doi:10.4236/ojpm.2017.75005
Iversen L, Sivasubramaniam S, Lee AJ, Fielding S, Hannaford PC. Lifetime cancer risk and combined oral contraceptives: the royal college of general practitioners’ oral contraception study. Am J Obstet Gynecol. 2017;216(6):580.e1-580.e9. doi:10.1016/j.ajog.2017.02.002
Liu ZC, Liu WD, Liu YH, Ye XH, Chen SD. Multiple sexual partners as a potential independent risk factor for cervical cancer: a meta-analysis of epidemiological studies. Asian Pac J Cancer Prev. 2015;16(9):3893–900. doi:10.7314/APJCP.2015.16.9.3893
Contreras-González R, Magaly-Santana A, Jiménez E, Gallegos R, Xeque Á, Palomé G, et al. Nivel de conocimientos en adolescentes sobre el virus del papiloma humano. Enferm Univ. 2017;14(2):104–10. doi:10.1016/j.reu.2017.01.002
Quabius ES, Fazel A, Knieling C, Gebhardt S, Laudien M, Moore C, et al. No association between HPV-status in tonsillar tissue and sexual behavior of the patients in a northern german population—critical view of the link between HPV natural history and HPV-driven carcinogenesis. Papillomavirus Res. 2020;10:100207. doi:10.1016/j.pvr.2020.100207
Asthana S, Busa V, Labani S. Oral contraceptives use and risk of cervical cancer—a systematic review & meta-analysis. Eur J Obstet Gynecol Reprod Biol. 2020;247:163–75. doi:10.1016/j.ejogrb.2020.02.021
Seefoó-Jarquín P, Sosa-Jurado F, Maycotte-González P. Panorama epidemiológico de las displasias cervicales en una unidad de primer nivel de atención. Rev Méd Inst Mex Seguro Soc. 2023;61(2):155–62.
Al Sekri E, Al Musalhi A. Prevalence of cytological abnormalities in papanicolaou smears and risk factors for cervical cancer among women in muscat, oman. Sultan Qaboos Univ Med J. 2021;21(4):598–603. doi:10.18295/squmj.4.2021.041
Terán C. Prevalencia y factores asociados a la infección por el virus del papiloma humano (VPH) y las lesiones causadas por el mismo en mujeres de 20 a 59 años en el municipio de sucre, bolivia [Doctoral dissertation] [Internet]. [Alcalá de Henares]: Universidad de Alcalá; 2014. Disponible en: https://dialnet.unirioja.es/servlet/tesis?codigo=113987
Medina ML, Medina MG, Merino LA. Principales conductas de riesgo sobre papilomavirus humano en universitarios argentinos. Av Odontoestomatol. 2018;34(6):311–9.
Barrenechea-Pulache A. Socio-demographic inequalities in the uptake of papanicolaou tests in Peru: analysis of the 2015–2017 demographic and family health survey. Epidemiol HEALTH. 2020;42:e2020043. doi:10.4178/epih.e2020043
Anastasiou E, McCarthy KJ, Gollub EL, Ralph L, van de Wijgert JHHM, Jones HE. The relationship between hormonal contraception and cervical dysplasia/cancer controlling for human papillomavirus infection: a systematic review. Contraception. 2022;107:1–9. doi:10.1016/j.contraception.2021.11.003
de Martel C, Plummer M, Vignat J, Franceschi S. Worldwide burden of cancer attributable to HPV by site, country and HPV type. Int J Cancer. 2017;141(4):664–70. doi:10.1002/ijc.30716
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Richard Henry Maita Hinostroza, Edison Suarez Buitron, Fernando Solorzano Latour
This work is licensed under a Creative Commons Attribution 4.0 International License.
